Herspiegel Consulting’s blend of clinical development experience, pharmaceutical marketing knowledge, and therapeutic expertise uniquely positions us to drive success across the pharmaceutical new product planning and development process.
We help our clients advance their new product planning strategies with actionable insights to evaluate market potential, prioritize markets during a product launch, and develop competitive lifecycle management plans. Herspiegel consultants have a deep understanding of our clients’ relevant markets and products. This understanding informs realistic, targeted, and data-driven recommendations for an optimized commercial strategy throughout the new product planning process. New product planning support includes landscape assessments, TPP development, forecasting, commercialization strategy, clinical design, budget development, and investor communications.
Evaluated market dynamics, emerging trends and consumer demands to assess the market and competitive landscape.
Identified treatment paradigm and market size, evaluated unmet needs, optimized patient profiles, and evaluated investment plans to ensure success across a tactical direction for disease states.
Prioritized pharmaceutical product launches and resources based on business and market impact.
Developed forecast models and assessments to inform and drive business decisions during the new product planning process.
Highlighted the commercial opportunity, clinical results, product portfolio, and financial position to investors.
Provided strategic models to manage the new product planning process from discovery through post-product launch management.
New product planning is the nexus point between development and commercial planning. Read our white paper to learn about the four key elements of successful new product planning.